Published on
May 16, 2025
FDA biosimilar approvals set for record-breaking year amid US pricing reforms
2024 saw the highest number of biosimilars approved by the US Food and Drug Administration (FDA) in a calendar year, with this year set to break this record again, analysis suggests. The FDA approved 19 biosimilars last year, a sharp jump from the five …
Source:
Pharmaceutical Technology
-
Pending
